Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2000
07/12/2000EP1018008A2 Method of identification of leads or active compounds
07/12/2000EP1017694A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives
07/12/2000EP1017693A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
07/12/2000EP1017682A1 Novel angiogenesis inhibitors
07/12/2000EP1017399A1 Camptothecin analogs and methods of preparation thereof
07/12/2000EP1017391A2 Sustained release tablet formulation to treat parkinson disease
07/12/2000EP1017384A1 Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
07/12/2000EP1017383A1 Thrombin inhibitors
07/12/2000EP0877734B1 Quinoline and quinazoline compounds useful in therapy
07/12/2000EP0628041B1 Heterocyclic compounds and their preparation and use
07/12/2000EP0561850B1 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds useful as antibacterial agents
07/12/2000CN1259948A 6,7-disubstituted-4-aminopyrido [2,3-D] pyrimidine compounds
07/12/2000CN1259947A 2-aryl-naphthyridin-4-ones as antitumor agent
07/12/2000CN1259942A Novel guanidine mimics as factor Xa inhibitors
07/12/2000CN1054377C New bicyclic derivatives of imidazole and their prepn. process, their use as medicaments and the pharmaceutical compositions containing them
07/11/2000US6087510 Method of use of imidazolium cations
07/11/2000US6087380 Antithrombotic benzimidazoles; anticoagulants; 2-(n-(4-amidinophenyl)-aminomethyl)-benzimidazol-5-yl-carboxylic acids
07/11/2000US6087374 Anti-viral compounds
07/11/2000US6087373 A serine protease inhibitor for preventing or treating unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis
07/11/2000US6087372 Method of enhancing cognition with 2-(4-methoxyphenyl)-pyrazolo[4,3-c]quinolin-3-one
07/11/2000CA2208569C Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
07/06/2000WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors
07/06/2000WO2000039128A1 5ht1 antagonists for antidepressant therapy
07/06/2000WO2000039127A1 1h-imidazo[4,5-d]pyridazin-7-ones, 3h-imidazo[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands
07/06/2000WO2000039108A1 Thrombin or factor xa inhibitors
07/06/2000WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
07/06/2000WO2000039082A2 1,2-annelated quinoline derivatives
07/06/2000WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
07/06/2000WO2000039073A1 Stereospecific ring opening of chiral azetidinium salts
07/06/2000WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
07/06/2000WO2000038720A1 Remedies for pain
07/06/2000WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
07/06/2000WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia
07/06/2000WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
07/06/2000WO2000038687A1 Protease inhibitors
07/06/2000WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS
07/06/2000WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000WO2000008021A3 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof
07/06/2000WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS
07/06/2000CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds
07/06/2000CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia
07/06/2000CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356671A1 Protease inhibitors
07/06/2000CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
07/06/2000CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
07/06/2000CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
07/06/2000CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
07/06/2000CA2356269A1 Pain control agent
07/06/2000CA2351724A1 1h-imidazo¬4,5-d|pyridazin-7-ones, 3h-imidazo¬4,5-c|pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands
07/06/2000CA2349557A1 Thrombin or factor xa inhibitors
07/06/2000CA2348740A1 Thrombin or factor xa inhibitors
07/06/2000CA2320730A1 Thrombin or factor xa inhibitors
07/05/2000EP1015451A1 Tetrahydro gamma-carbolines
07/05/2000EP1015450A1 Novel pyridazine compounds
07/05/2000EP1015445A1 Antimicrobial quinolones, their compositions and uses
07/05/2000EP1015435A1 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
07/05/2000EP1015434A2 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
07/05/2000EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
07/05/2000EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
07/05/2000EP0626961B1 Process for the preparation of cyano-methoxyiminomethyl derivatives
07/05/2000EP0586585B1 1,2-dihydropyrido(3,4-b)pyrazines as fungicides
07/05/2000EP0565621B1 Method of making camptothecin and camptothecin analogs
07/05/2000CN1259140A Treatment of insulin resistance with growth hormone secretagogues
07/05/2000CN1259132A Compounds
07/05/2000CN1259131A Compounds
07/05/2000CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component
07/05/2000CN1258672A Amino-compound
07/04/2000US6084120 β-Alkoxyacrylates against malaria
07/04/2000US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer
07/04/2000US6083957 Heterocyclic compounds and their preparation and use
07/04/2000US6083952 Compounds
07/04/2000US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
07/04/2000US6083677 Photographic element containing yellow dye-forming photographic coupler
07/04/2000US6083505 Immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1h-imidazo(4,5-c)quinolin-4-amine in an amount effective to increase the immune response to the
07/04/2000CA2016142C Sulfonamides
07/04/2000CA1341043C Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
06/2000
06/29/2000WO2000037470A1 Antihistaminic spiro compounds
06/29/2000WO2000037469A2 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000WO2000037468A1 DIBENZO[a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
06/29/2000WO2000037467A1 1,8-benzonaphthyridine derivatives
06/29/2000WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS
06/29/2000WO2000037465A2 Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037074A1 Mutilin 14-ester derivatives having antibacterial activity
06/29/2000WO2000037021A2 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
06/29/2000WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000010973A3 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2394949A1 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
06/29/2000CA2357760A1 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2355469A1 Dibenzo[a,g]quinolizinium derivatives and the salts thereof
06/29/2000CA2352858A1 Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
06/28/2000EP1012892A1 Electroluminescent device